Company attributes
Funding Round attributes
Other attributes
Alex Therapeutics develops CE-certified Digital Therapeutics (DTx) products. The company combines Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) with Artificial Intelligence to provide patients with personalized and effective care.
Democratize healthcare through Psychology, Design & Technology.
Cognitive behavioral therapy has been proven effective in treating a wide range of mental health disorders and can be immensely powerful – but it is still vastly under-utilized. By empowering CBT with technology and design, we can lower the threshold to access high-quality psychological treatment, break the stigma of receiving help, and treat a wide range of medical indications that are currently left untreated.
40% of all premature deaths result from poor behavioral patterns.
Our habits are literarily killing us and mental health disorders are more common than ever.
We're a dedicated team of psychologists, engineers and designers determined to fight this by providing digitally delivered, high-quality care to millions of people.
Alex Therapeutics is founded by John Drakenberg Renander, an entrepreneur by heart with a degree in both Psychology and Business, and Oliver Fleetwood, PhD in Theoretical Computational Molecular Biophysics.
The company is backed by the King founders (Candy Crush) through the VC firm Sweet Studio.
